Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance

Immunity - United States
doi 10.1016/j.immuni.2013.06.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept

Clinical Cancer Research
Cancer ResearchOncology
2013English

Metal-Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics

European Journal of Inorganic Chemistry
Inorganic Chemistry
2016English

Dermatomyositis: A Slow Path Towards Targeted Therapies or Will Conventional Therapies Prevail?

British Journal of Dermatology
DermatologyMedicine
2018English

Oral Mucositis and Stomatitis Associated With Conventional and Targeted Anticancer Therapy

Journal of Pharmacovigilance
2013English

Autophagy in Natural and Therapy-Driven Anticancer Immunosurveillance

Autophagy
Cell BiologyMolecular Biology
2017English

Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action

International Journal of Biomaterials
BiomaterialsBiomedical Engineering
2018English

ATM Activation Mediates Anticancer Immunosurveillance by Natural Killer and T Cells

OncoImmunology
OncologyAllergyImmunology
2013English

Targeted Cancer Therapies

Chinese Journal of Cancer
2011English

Design, Synthesis and in Vitro Activity of Anticancer Styrylquinolines. The P53 Independent Mechanism of Action

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy